Mucosal correlates of isolated HIV semen shedding during effective antiretroviral therapy

Mucosal Immunology

Volumn 5, Issue 3, 2012, Pages 248-257

  Sheth, P M ^a   Yi, T J ^a   Kovacs, C ^a,b   Kemal, K S ^c   Jones, R B ^a   Osborne, B ^a   Pilon, R ^d   La Porte, C ^e   Ostrowski, M ^a   Mazzulli, T ^a,f   Burger, H ^c   Weiser, B ^c   Kaul, R ^a,g  

^a UNIVERSITY OF TORONTO   (Canada)

^b MAPLE LEAF MEDICAL CLINIC   (Canada)

^c WADSWORTH CENTER   (United States)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^f MOUNT SINAI HOSPITAL   (Canada)

^g UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CXCL9 CHEMOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1B; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; UNCLASSIFIED DRUG; VIRUS DNA;

ARTICLE; BLOOD LEVEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATED HIV SEMEN SHEDDING; MALE; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEMINAL PLASMA; T LYMPHOCYTE ACTIVATION; VIRUS ACTIVATION; VIRUS SHEDDING;

EID: 84857362006     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2012.1     Document Type: Article

References (45)

1. Hladik , F. & McElrath , M. J. Setting the stage: Host invasion by HIV. Nat. Rev. Immunol. 8 , 447-457 ( 2008 ).
2. Quinn , T. C. et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl. J. Med. 342 , 921-929 ( 2000 ).
3. Kovacs , A. et al. Determinants of HIV-1 shedding in the genital tract of women. Lancet 358 , 1593-1601 ( 2001 ).
4. Xu , C. , Politch , J. A. , Tucker , L. , Mayer , K. H. , Seage , G. R. III & Anderson , D. J. Factors associated with increased levels of human immunodeficiency virus type 1 DNA in semen. J. Infect. Dis. 176 , 941-947 ( 1997 ).
5. Anderson , J. A. et al. HIV-1 populations in semen arise through multiple mechanisms. PLoS Pathog. 6 , e1001053 ( 2010 ).
6. Baeten , J. M. et al. Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci. Transl. Med. 3 , 77ra29 ( 2011 ).
7. Marcelin , A. G. et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma. AIDS 22 , 1677-1679 ( 2008 ).
8. Sheth , P. M. et al. Persistent HIV RNA shedding in semen despite effective antiretroviral therapy. AIDS 23 , 2050-2054 ( 2009 ).
9. Neely , M. N. et al. Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 44 , 38-42 ( 2007 ).
10. Fiore , J. R. et al. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS 17 , 2169-2176 ( 2003 ).
11. Montaner , J. S. et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 368 , 531-536 ( 2006 ).
12. Donnell , D. et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis. Lancet 375 , 2092-2098 ( 2010 ).
13. Cohen , M. S. et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl. J. Med. 365 , 493-505 ( 2011 ).
14. Barroso , P. F. et al. Effect of antiretroviral therapy on HIV shedding in semen. Ann. Intern. Med. 133 , 280-284 ( 2000 ).
15. Halfon , P. et al. Semen may harbor HIV despite effective HAART: Another piece in the puzzle. PLoS ONE 5 , e10569 ( 2010 ).
16. Lorello , G. , la Porte , C. , Pilon , R. , Zhang , G. , Karnauchow , T. & MacPherson , P. Discordance in HIV-1 viral loads and antiretroviral drug concentrations comparing semen and blood plasma. HIV Med. 10 , 548-554 ( 2009 ).
17. Cu-Uvin , S. et al. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. AIDS 24 , 2489-2497 ( 2010 ).
18. Sheth , P. M. et al. Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation. J. Infect. Dis. 193 , 45-48 ( 2006 ).
19. Butler , D. M. et al. Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men. AIDS 22 , 1667-1671 ( 2008 ).
20. Gupta , P. et al. Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen. J. Infect. Dis. 182 , 79-87 ( 2000 ).
21. Berlier , W. , Bourlet , T. , Levy , R. , Lucht , F. , Pozzetto , B. & Delezay , O. Amount of seminal IL-1beta positively correlates to HIV-1 load in the semen of infected patients. J. Clin. Virol. 36 , 204-207 ( 2006 ).
22. Sheth , P. M. et al. HIV-specific CD8+ lymphocytes in semen are not associated with reduced HIV shedding. J. Immunol. 175 , 4789-4796 ( 2005 ).
23. Reddy , Y. S. et al. Pharmacokinetic and pharmacodynamic investigation of efavirenz in the semen and blood of human immunodeficiency virus type 1-infected men. J. Infect. Dis. 186 , 1339-1343 ( 2002 ).
24. Taylor , S. et al. Antiretroviral drug concentrations in semen of HIV-infected men: Differential penetration of indinavir, ritonavir and saquinavir. J. Antimicrob. Chemother. 48 , 351-354 ( 2001 ).
25. Barau , C. et al. High concentration of raltegravir in semen of HIV-infected men: Results from a substudy of the EASIER-ANRS 138 trial. Antimicrob. Agents Chemother. 54 , 937-939 ( 2010 ).
26. Antiretrovirals for prevention: Maraviroc exposure in the semen and rectal tissue of healthy male volunteers after single and multiple dosing (paper # 85). Proceedings of the 17th Conference on Retroviruses and Opportunistic Infections (CROI); February 16-19 2010; San Francisco, CA .
27. Kashuba , A. D. , Dyer , J. R. , Kramer , L. M. , Raasch , R. H. , Eron , J. J. & Cohen , M. S. Antiretroviral-drug concentrations in semen: Implications for sexual transmission of human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 43 , 1817-1826 ( 1999 ).
28. Rebbapragada , A. et al. Negative mucosal synergy between herpes simplex type 2 and HIV in the female genital tract. AIDS 21 , 589-598 ( 2007 ).
29. Attia , S. , Egger , M. , Muller , M. , Zwahlen , M. & Low , N. Sexual transmission of HIV according to viral load and antiretroviral therapy: Systematic review and meta-analysis. AIDS 23 , 1397-1404 ( 2009 ).
30. Statement: Antiretroviral therapy and sexual transmission of HIV , www.who.int/entity/hiv/mediacentre/080201-hivtransmission-en.pdf ( 2008 ). Accessed Date Accessed 2008 Accessed .
31. Vernazza , P. , Hirschel , B. , Bernasconi , E. & Flepp , M. Les personnes s é ropositives ne souffrant d'aucune autre MST et suivant un traitement antir é troviral efficace ne transmettent pas le VIH par voie sexuelle (HIV-positive individuals without additional sexually transmitted diseases and on effective anti-retroviral therapy are sexually non-infectious). Bulletin Des Médecins Suisses 89 , 165-169 ( 2008 ).
32. Orendi , J. M. et al. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. J. Infect. Dis. 178 , 1279-1287 ( 1998 ).
33. Sheth , P. M. et al. Immune reconstitution in the sigmoid colon after long-term HIV therapy. Mucosal. Immunol. 1 , 382-388 ( 2008 ).
34. Kaul , R. et al. The genital tract immune milieu: An important determinant of HIV susceptibility and secondary transmission. J. Reprod. Immunol. 77 , 32-40 ( 2008 ).
35. Zhu , J. et al. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat. Med. 15 , 886-892 ( 2009 ).
36. Amara , A. et al. HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186 , 139-146 ( 1997 ).
37. Coombs , R. W. et al. Lower genitourinary tract sources of seminal HIV. J. Acquir. Immune Defic. Syndr. 41 , 430-438 ( 2006 ).
38. Kalichman , S. C. et al. Human immunodeficiency virus in semen and plasma: Investigation of sexual transmission risk behavioral correlates. AIDS Res. Hum. Retroviruses 17 , 1695-1703 ( 2001 ).
39. DHHS. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents , 1-161 ( 2009 ).
40. Sheth , P. M. et al. HIV viral shedding in semen: Lack of correlation with systemic virus-specific CD8 responses. AIDS 18 , 2202-2205 ( 2004 ).
41. Fang , G. et al. Long-term survivors in Nairobi: Complete HIV-1 RNA sequences and immunogenetic associations. J. Infect. Dis. 190 , 697-701 ( 2004 ).
42. Fang , G. et al. Recombination following superinfection by HIV-1. AIDS 18 , 153-159 ( 2004 ).
43. Kemal , K. S. et al. HIV-1 drug resistance in variants from the female genital tract and plasma. J. Infect. Dis. 195 , 535-545 ( 2007 ).
44. Bertagnolio , S. et al. HIV-1 drug resistance surveillance using dried whole blood spots. Antivir. Ther. 12 , 107-113 ( 2007 ).
45. Kemal , K. S. et al. HIV-1 in genital tract and plasma of women: Compartmentalization of viral sequences, coreceptor usage, and glycosylation. Proc. Natl Acad. Sci. USA 100 , 12972-12977 ( 2003 ).